Promoting Benzodiazepine Cessation Through an Electronically-delivered Patient Self-management Intervention

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Benzodiazepines (e.g., Ativan, Xanax) are widely prescribed medications that are used mainly to treat anxiety and sleeping difficulties. Long-term use of benzodiazepine carries risks of physical dependence, addiction, falls and other accidents, and problems in thinking/concentrating. Researchers in Canada developed a printed self-help packet that enabled many individuals to reduce or cease taking benzodiazepines on their own. This study is designed to tailor that packet to the Veteran population, convert it to an app that people can use on their laptop or smart phone, and test whether the app helps promote benzodiazepine prescribing.
Epistemonikos ID: fe2e4241aa612b8dc8e6a776249bc046d0e54fff
First added on: May 07, 2024